Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Energy
DIG
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Exelixis (EXEL)
- 57.670
- -1.340-2.27%
Close Sep 8 16:00 ET
- 57.800
- +0.130+0.23%
Post 19:30 ET
14.29BMarket Cap18.14P/E (TTM)
59.410High57.550Low2.54MVolume58.970Open59.010Prev Close147.63MTurnover1.19%Turnover Ratio20.74P/E (Static)247.78MShares59.72052wk High7.75P/B12.32BFloat Cap33.75552wk Low--Dividend TTM213.60MShs Float59.720Highest--Div Yield TTM3.15%Range %1.260Lowest58.145Avg Price1Lot Size
Exelixis (EXEL) News
Guggenheim Remains a Hold on Exelixis (EXEL)
Exelixis (EXEL) Receives a Hold From BMO Capital
BMO Capital Initiates Coverage On Exelixis With Market Perform Rating, Announces Price Target of $54
Truist Securities Maintains Hold on Exelixis, Lowers Price Target to $52
Goldman Sachs Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $64
Analysts' Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)
Stifel Maintains Hold on Exelixis, Raises Price Target to $51
RBC Capital Sticks to Their Hold Rating for Exelixis (EXEL)
Exelixis: Buy Rating Reaffirmed on Cabozantinib Resilience, Cost Discipline and Zanzalintinib Upside Despite Near-Term NET Guidance Cut
BofA Securities Maintains Exelixis(EXEL.US) With Sell Rating, Maintains Target Price $41
Bank of America Securities Reaffirms Their Sell Rating on Exelixis (EXEL)
William Blair Maintains Exelixis(EXEL.US) With Buy Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA), Exelixis (EXEL) and Editas Medicine (EDIT)
Truist Financial Maintains Exelixis(EXEL.US) With Hold Rating
Morgan Stanley Maintains Equal-Weight on Exelixis, Raises Price Target to $53
Goldman Sachs Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $64
Exelixis (EXEL) Gets a Buy From Goldman Sachs
Barclays Maintains Equal-Weight on Exelixis, Raises Price Target to $49
Exelixis Price Target Raised to $49.00/Share From $40.00 by Wells Fargo
Wells Fargo Maintains Equal-Weight on Exelixis, Raises Price Target to $49
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm